Cogent Biosciences, Inc. Financial Ratios — COGT Stock

Profitability (USD)

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-47.98	-40.9	-51.14	-47.04	-49.82	-29.93	-52.63	-62.65	-79.79	-51.99
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	- -	- -	- -	- -	- -
EBITDA Margin (%)	-214.77	-287.02	-298.82	-356.32	-137.27	-439.19	- -	- -	- -	- -	- -
Operating Margin (%)	-220.76	-300.08	-312.82	-369.89	-143.02	-448.34	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	511.52	- -	- -	- -	- -
Pretax Margin (%)	-220.76	-285.19	-304.93	-354.76	-141.49	-950.43	- -	- -	- -	- -	- -
Profit Margin (%)	-220.76	-285.19	-304.93	-354.76	-141.49	-950.43	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-222.2	-286.2	-305.71	-354.92	-141.49	-2,276.81	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	0.65	0.35	0.25	0.05	- -	58.26	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	- -	6	5	3	20	19	17	239
ST Debt	- -	- -	- -	- -	2	2	2	1	1	2	2
LT Debt	- -	- -	- -	- -	4	3	1	18	17	16	237
Total Debt/EBITDA	- -	- -	- -	- -	-0.2	-0.15	-0.04	-0.14	-0.09	-0.06	-0.73
Net Debt/EBITDA	- -	2.27	1.13	1.61	1.21	7.01	2.99	0.99	0.26	0.36	0.27
Total Debt/EBIT	- -	- -	- -	- -	-0.19	-0.15	-0.04	-0.13	-0.09	-0.06	-0.72
Net Debt/EBIT	- -	2.17	1.08	1.55	1.16	6.86	2.91	0.95	0.26	0.36	0.27
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-107.37
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-107.88
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-108.87
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3
Common Equity/Total Assets	- -	-34.2	-104.51	-107.1	-250.66	-79.18	-116.73	-136.68	-192.55	-262.09	-126.73
Long-Term Debt/Equity (%)	- -	- -	- -	- -	13.89	1.34	0.39	7.13	6.78	6.2	37.28
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-3.74	-3.82	-0.46	-5.6	-3.33	-2.17	-27.58
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	8.93	1.26	0.36	6.06	5.57	4.85	25.3
Total Debt/Equity (%)	- -	- -	- -	- -	18.99	2.22	1.47	7.68	7.31	6.82	37.52
Total Debt/Capital (%)	- -	- -	- -	- -	-5.12	-6.31	-1.73	-6.03	-3.59	-2.39	-27.76
Total Debt/Total Assets (%)	- -	- -	- -	- -	12.2	2.08	1.36	6.53	6.01	5.33	25.47
Net Debt to Equity	- -	-78.87	-99.88	-92.42	-117.83	-103.21	-102.57	-54.7	-20.65	-38.3	-14
Net Debt/Capital (%)	- -	-416.21	1,154.82	37.69	24.1	74.57	54.64	30.05	9.21	11.83	7.6
EBITDA	-6	-18	-25	-35	-31	-35	-74	-142	-205	-272	-329
EBITDA-CapEx	-8	-22	-26	-35	-31	-35	-75	-149	-207	-272	-330
Operating Income (Loss)	-7	-19	-26	-36	-32	-35	-76	-148	-208	-276	-333

Liquidity (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	7.84	3.66	3.15	2.82	18.5	12.86	9.66	6.96	5.15	14.08
Current Ratio	- -	7.98	3.79	3.25	3.06	18.7	13.04	9.87	7.09	5.32	14.23
Quick Ratio	- -	7.95	3.73	3.22	2.98	18.5	12.86	9.66	6.96	5.15	14.08
CFO/Avg Current Liab	- -	-4.27	-2.59	-1.8	-2.17	-2.72	-3.9	-5.4	-4.73	-4.43	-4.42
Common Equity/Total Assets	- -	-34.2	-104.51	-107.1	-250.66	-79.18	-116.73	-136.68	-192.55	-262.09	-126.73
Long-Term Debt/Equity (%)	- -	- -	- -	- -	13.89	1.34	0.39	7.13	6.78	6.2	37.28
Long-Term Debt/Capital (%)	- -	- -	- -	- -	-3.74	-3.82	-0.46	-5.6	-3.33	-2.17	-27.58
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	8.93	1.26	0.36	6.06	5.57	4.85	25.3
Total Debt/Equity (%)	- -	- -	- -	- -	18.99	2.22	1.47	7.68	7.31	6.82	37.52
Total Debt/Capital (%)	- -	- -	- -	- -	-5.12	-6.31	-1.73	-6.03	-3.59	-2.39	-27.76
Total Debt/Total Assets (%)	- -	- -	- -	- -	12.2	2.08	1.36	6.53	6.01	5.33	25.47
CFO/Total Liabilities	- -	-80.48	-124.15	-126.45	-235.06	-220.63	-328.14	-263.2	-276.13	-290.16	-87.79
CFO/CapEx	8.88	-5.64	-28.33	-59.18	-1,258	- -	-34.18	-17.29	-54.94	-362.64	-170.17
Altman's Z-Score	- -	-0.26	-2.29	0.57	-3.79	4.16	10.95	6.45	1.05	1.65	-1.86

Working Capital (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	13.7	9.51	7.79	12.27	7.87	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	26.65	38.38	46.83	29.75	46.37	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	110	22	124	376	679	468	862	- -
- Cash & Cash Equivalents	- -	41	28	56	37	242	220	140	53	98	312
+ Preferred Equity and Hybrid Capital	- -	77	77	- -	- -	111	85	66	60	111	89
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	6	5	3	20	19	17	239
Enterprise Value	- -	9	36	31	-9	-2	245	505	282	703	-573
Total Capital	- -	51	26	-92	-118	-83	-182	-326	-525	-731	-860
Total Debt/Capital (%)	- -	- -	- -	- -	-5.12	-6.31	-1.73	-6.03	-3.59	-2.39	-27.76
Total Debt / EV	- -	- -	- -	- -	-0.64	-3.14	0.01	0.04	0.07	0.02	-0.42
EV/Sales	- -	1.35	4.33	3.18	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	110	22	124	376	679	468	862	- -
Diluted Enterprise Value	- -	36	49	54	-9	-2	245	625	494	892	16
EV per Share	- -	1.46	4.89	4.97	- -	- -	5.59	8.6	3.53	6.36	- -
TTM Sales	3	6	8	10	22	8	- -	- -	- -	- -	- -
TTM EBITDA	-6	-18	-25	-35	-31	-35	-74	-142	-205	-272	-329
TTM Operating Income	-7	-19	-26	-36	-32	-35	-76	-148	-208	-276	-333
TTM Cash Flow to Firm	18	-19	-26	-32	-42	-36	-59	-119	-154	-208	-261
TTM Free Cash Flow to Firm	20	-15	-25	-32	-41	-36	-57	-112	-151	-207	-260

Multiples (USD)

API Chat

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-3.43	-0.53	-3.47	-6.59	-6.07	-3.11	-4.16	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	9	36	31	-9	-2	245	505	282	703	-573
Low Price	- -	- -	- -	10	1.9	1.18	5.83	3.79	3.67	4.28	3.72
EV/Sales	- -	1.35	4.33	3.18	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-8.02	-2.53	-0.41	-5.21	-4.19	-4.53	-3.62	- -
Price/Earnings High	- -	- -	- -	-12.73	-4.86	-0.92	-8.02	-7.57	-6.49	-5.44	- -
Price/Earnings Low	- -	- -	- -	-1.8	-0.45	-0.07	-3.53	-1.59	-1.52	-1.85	- -
Price/Book Value	- -	- -	- -	-1.19	-0.18	-0.63	-1.39	-1.65	-0.78	-1	- -
Price/Book Value Average	- -	- -	- -	-3.01	-0.65	-0.37	-1.39	-1.43	-1.44	-1.08	- -
Price/Book Value High	- -	- -	- -	-4.78	-1.25	-0.83	-2.14	-2.58	-2.07	-1.62	- -
Price/Book Value Low	- -	- -	- -	-0.68	-0.12	-0.07	-0.94	-0.54	-0.48	-0.55	- -
Price/Tangible Book Value	- -	- -	- -	1.82	0.69	1.01	2.92	3.58	2.37	5.91	- -
Price/Tangible Book Value Average	- -	- -	- -	4.6	2.53	0.59	2.92	3.1	4.41	6.37	- -
Price/Tangible Book Value High	- -	- -	- -	7.3	4.88	1.33	4.5	5.59	6.32	9.56	- -
Price/Tangible Book Value Low	- -	- -	- -	1.03	0.46	0.11	1.98	1.17	1.48	3.25	- -
Price/Sales	- -	- -	- -	11.25	0.98	15.81	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	28.46	3.58	9.24	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	45.17	6.88	20.95	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	6.39	0.64	1.66	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-3.37	-0.53	-3.47	-6.4	-5.72	-3.05	-4.15	- -
Price/Cash Flow Average	- -	- -	- -	-8.53	-1.94	-2.03	-6.41	-4.96	-5.67	-4.46	- -
Price/Cash Flow High	- -	- -	- -	-13.53	-3.73	-4.6	-9.87	-8.95	-8.13	-6.7	- -
Price/Cash Flow Low	- -	- -	- -	-1.92	-0.35	-0.36	-4.35	-1.88	-1.9	-2.28	- -
Price/Free Cash Flow Average	- -	- -	- -	-8.67	-1.94	-2.03	-6.6	-5.26	-5.78	-4.48	- -
Price/Free Cash Flow High	- -	- -	- -	-13.77	-3.73	-4.6	-10.17	-9.5	-8.28	-6.72	- -
Price/Free Cash Flow Low	- -	- -	- -	-1.95	-0.35	-0.36	-4.48	-1.99	-1.94	-2.28	- -
EV/Sales Average	- -	5.63	5.85	22.74	2.18	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	5.63	5.85	39.45	5.49	4.93	- -	- -	- -	- -	- -
EV/Sales Low	- -	5.63	5.85	0.67	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	- -	-1.96	-1.96	-6.38	-1.59	1.55	-3.34	-3.76	-4.38	-3.53	-0.05
EV/EBITDA High	- -	-1.96	-1.96	-11.07	-4	-1.12	-6.1	-7.09	-6.23	-5.24	-0.05
EV/EBITDA Low	- -	-1.96	-1.96	-0.19	0.55	3.27	-1.69	-1.18	-1.55	-1.85	-0.05
EV/EBIT Average	- -	-1.88	-1.87	-6.15	-1.53	1.51	-3.25	-3.61	-4.31	-3.47	-0.05
EV/EBIT High	- -	-1.88	-1.87	-10.66	-3.84	-1.1	-5.94	-6.81	-6.12	-5.16	-0.05
EV/EBIT Low	- -	-1.88	-1.87	-0.18	0.53	3.2	-1.64	-1.14	-1.53	-1.82	-0.05
Last Price	- -	- -	- -	17.6	2.88	11.23	8.58	11.56	5.88	7.8	35.52
High Price	- -	- -	- -	70.64	20.32	14.88	13.24	18.07	15.68	12.61	43.73
Enterprise Value Average	- -	36	49	221	49	-53	245	534	897	957	16
Enterprise Value High	- -	36	49	384	123	39	449	1,007	1,275	1,423	16
Enterprise Value Low	- -	36	49	7	-17	-113	124	168	318	503	16

	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	7	7	8	8	32	44	70	86	110	161
Diluted Weighted Avg Shares	7	7	7	6	8	11	44	59	80	110	- -
Basic Weighted Avg Shares	6	6	7	6	8	11	44	59	80	110	- -
Revenue per Share	0.51	1.09	1.13	1.56	2.95	0.71	- -	- -	- -	- -	- -
EBITDA per Share	-1.1	-3.12	-3.38	-5.57	-4.05	-3.12	-1.68	-2.42	-2.57	-2.46	- -
Operating Income per Share	-1.13	-3.26	-3.54	-5.78	-4.22	-3.18	-1.72	-2.52	-2.61	-2.5	- -
Basic EPS, GAAP	-1.13	-3.11	-3.46	-5.55	-4.18	-16.17	-1.65	-2.39	-2.42	-2.32	- -
Basic EPS from Cont Ops	-1.13	-3.1	-3.45	-5.55	-4.18	-6.75	-1.65	-2.39	-2.42	-2.32	- -
Diluted EPS, GAAP	-0.9	-2.46	-3.46	-5.55	-4.18	-16.17	-1.65	-2.39	-2.42	-2.32	- -
Diluted EPS from Cont Ops	-0.89	-2.45	-3.45	-5.55	-4.18	-6.75	-1.65	-2.39	-2.42	-2.32	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	3.03	-3.18	-3.49	-5.22	-5.45	-3.24	-1.34	-2.02	-1.93	-1.88	- -
Free Cash Flow per Basic Share	2.69	-3.75	-3.62	-5.31	-5.45	-3.24	-1.38	-2.14	-1.96	-1.89	- -
Cash & Equivalents per Share	- -	11.7	5.54	12.63	4.91	21.86	5.01	4.41	3.34	2.6	- -
Book Value per Share	- -	-4.41	-6.94	-14.79	-16.26	-17.93	-6.18	-7	-7.58	-7.78	- -
Tangible Book Value per Share	- -	-4.22	-6.6	9.68	4.17	11.17	2.94	3.23	2.48	1.32	- -

Cogent Biosciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)